Description
Arganova®
(argatroban)
Arganova® is an anticoagulant (a substance that prevents blood clots from forming in the bloodstream). It blocks the effect of thrombin, a substance in the blood that plays an important role in blood coagulation.
Arganova® can be prescribed to patients suffering from type II heparin-induced thrombocytopenia (type II HIT).
Type 2 heparin-induced thrombocytopenia increases the risk of blood clots in the bloodstream. These blood clots may lead to heart attacks, strokes, breathing difficulty and issues with blood supply to the limbs. Arganova® may prevent these problems, or prevent them from getting worse.
Report adverse events
For all your medical questions, reports of any side effects and product quality complaints, please contact Goodlife via +31-(0)85-0646016 or by e-mail via info@goodlifepharma.com
What is Arganova®?
Arganova® is a direct thrombin inhibitor. Arganova® is a prescription drug that is exclusively used in hospitals.
Who is Arganova® for?
Arganova® is for patients suffering from heparin-induced thrombocytopenia (HIT).
What does Arganova® do?
It blocks the effect of thrombin, a substance in the blood that plays an important role in blood coagulation.
Arganova® is a form of anticoagulant therapy. As a result of exposure to heparin (anticoagulant therapy), some patients develop HIT. If there are any suspicions of HIT, heparin administration should be ceased. If parenteral anticoagulant therapy is necessary in these cases, Arganova® can be administered.
Read the insert for more information about Arganova®.
